Who owns AURA BIOSCIENCES INC?
- Ticker: AURA
- CUSIP Number: 05153u107
Tip: Access positions for across all investors
Analyze quarterly positions in Aura Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aura Biosciences stock
Who bought or sold AURA BIOSCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Eventide Asset Management | 5.8M | $46M | 0% | Mar 2024 |
|
| Adage Capital Partners GP | 4.5M | $35M | 55% | Mar 2024 |
|
| Citadel Advisors | 3.7M | $29M | 1% | Mar 2024 |
|
| Medicxi Ventures Management | 3.0M | $24M | 0% | Mar 2024 |
|
| BlackRock | 2.4M | $19M | 31% | Mar 2024 |
|
| Vanguard Group | 1.7M | $13M | -2% | Mar 2024 |
|
| Franklin Resources | 1.5M | $11M | 142% | Mar 2024 |
|
| Nantahala Capital Management | 1.3M | $10M | 0% | Mar 2024 |
|
| Goldman Sachs Group | 997k | $7.8M | -4% | Mar 2024 |
|
| Regency Capital Management | 785k | $6.2M | 11% | Mar 2024 |
|
| Geode Capital Management | 781k | $6.1M | 48% | Mar 2024 |
|
| T. Rowe Price Associates | 596k | $4.7M | -10% | Mar 2024 |
|
| Decheng Capital | 516k | $4.6M | 100% | Dec 2023 |
|
| Long Focus Capital Management | 495k | $3.9M | 46% | Mar 2024 |
|
| Ensign Peak Advisors | 357k | $2.8M | 100% | Mar 2024 |
|
| Northern Trust | 296k | $2.3M | 34% | Mar 2024 |
|
| FMR | 295k | $2.3M | -18% | Mar 2024 |
|
| Leucadia National Corporation | 223k | $1.7M | 100% | Mar 2024 |
|
| Dimensional Fund Advisors | 209k | $1.6M | 17% | Mar 2024 |
|
| Platinum Investment Mangement | 180k | $1.4M | 100% | Mar 2024 |
|
| Verition Fund Management | 152k | $1.2M | 197% | Mar 2024 |
|
| Two Sigma Investments | 114k | $894k | 169% | Mar 2024 |
|
| Levin Capital Strategies | 111k | $873k | 11% | Mar 2024 |
|
| TD Asset Management | 108k | $847k | 0% | Mar 2024 |
|
| Charles Schwab Investment Management | 106k | $834k | 16% | Mar 2024 |
|
| D. E. Shaw & Co | 95k | $749k | 59% | Mar 2024 |
|
| Bank of New York Mellon | 95k | $742k | 5% | Mar 2024 |
|
| Morgan Stanley | 87k | $682k | 312% | Mar 2024 |
|
| Connor, Clark & Lunn Investment Management | 72k | $563k | 455% | Mar 2024 |
|
| Millennium Management | 71k | $555k | 100% | Mar 2024 |
|
| Nuveen Asset Management | 70k | $551k | 17% | Mar 2024 |
|
| UBS O'Connor | 67k | $529k | 100% | Mar 2024 |
|
| TBH Global Asset Management | 60k | $474k | 0% | Mar 2024 |
|
| New York Life Investment Management | 47k | $367k | 100% | Mar 2024 |
|
| Rhumbline Advisers | 46k | $357k | 14% | Mar 2024 |
|
| Exchange Traded Concepts | 38k | $300k | 156% | Mar 2024 |
|
| Marshall Wace | 37k | $292k | 100% | Mar 2024 |
|
| UBS Group | 37k | $288k | 18% | Mar 2024 |
|
| Bank of America Corporation | 35k | $274k | -1% | Mar 2024 |
|
| ALPS Advisors | 34k | $298k | 20% | Dec 2023 |
|
| Two Sigma Advisers | 32k | $247k | 100% | Mar 2024 |
|
| Values First Advisors | 27k | $214k | 150% | Mar 2024 |
|
| Barclays | 25k | $199k | -33% | Mar 2024 |
|
| Jpmorgan Chase & Co | 24k | $191k | 32% | Mar 2024 |
|
| Letko, Brosseau & Associates | 21k | $166k | 100% | Mar 2024 |
|
| Jane Street | 21k | $165k | -27% | Mar 2024 |
|
| Susquehanna International | 18k | $144k | 100% | Mar 2024 |
|
| Virtu Financial | 18k | $144k | 100% | Mar 2024 |
|
| Trexquant Investment | 17k | $154k | 65% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 16k | $124k | 43% | Mar 2024 |
|
| MetLife Investment Advisors | 15k | $133k | 0% | Dec 2023 |
|
| Wealth Enhancement Advisory Services | 15k | $116k | 100% | Mar 2024 |
|
| American International | 14k | $122k | 1% | Dec 2023 |
|
| Wells Fargo & Company | 13k | $102k | 51% | Mar 2024 |
|
| Alliancebernstein | 13k | $115k | 21% | Dec 2023 |
|
| SG Americas Securities | 12k | $97k | -35% | Mar 2024 |
|
| Mirae Asset Global Investments | 12k | $108k | -6% | Mar 2024 |
|
| XTX Topco | 12k | $91k | 100% | Mar 2024 |
|
| Squarepoint Ops | 10k | $82k | 100% | Mar 2024 |
|
| Citigroup | 6.7k | $54k | 66% | Mar 2024 |
|
| New York State Common Retirement Fund | 6.4k | $50k | 0% | Mar 2024 |
|
| California State Teachers Retirement System | 3.6k | $28k | -41% | Mar 2024 |
|
| Tower Research Capital | 3.2k | $25k | -52% | Mar 2024 |
|
| Legal & General Group | 2.9k | $23k | 24% | Mar 2024 |
|
| Summit Investment Advisors | 2.3k | $18k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 1.7k | $14k | -84% | Mar 2024 |
|
| Metropolitan Life Insurance Company | 1.6k | $14k | 0% | Dec 2023 |
|
| Amalgamated Bank | 1.2k | $10k | -42% | Mar 2024 |
|
| CWM | 40.00 | $0 | 8% | Mar 2024 |
|
| NISA Investment Advisors | 26.00 | $204.001200 | 160% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 4.00 | $31.000000 | 100% | Mar 2024 |
|
Who sold out of Aura Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Rock Springs Capital Management | Sep 2023 | 723k | $6.5M |
| Monashee Investment Management | Dec 2023 | 198k | $1.8M |
| Alyeska Investment Group | Dec 2023 | 76k | $673k |
| Hudson Bay Capital Management | Dec 2023 | 53k | $470k |
| State of Wisconsin Investment Board | Dec 2023 | 30k | $264k |
| Martingale Asset Management | Sep 2023 | 25k | $221k |
| Water Island Capital | Sep 2023 | 23k | $203k |
| Walleye Trading Advisors | Dec 2023 | 18k | $160k |
| Ing Investment Management | Sep 2023 | 12k | $106k |
| Fortitude Family Office | Dec 2023 | 227.00 | $2.0k |
| Coppell Advisory Solutions | Sep 2023 | 100.00 | $2.0k |